Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sowalsky
    Junior Member
    • Oct 2012
    • 4

    #1

    BCFTools missing mutation at 8%

    I am having difficulty figuring out why bcftools is not calling my SNP. When I run samtools mpileup, the position is being "piled up" properly but it is not being interpreted as a SNP. It is a position read at extremely high depth (100,000x).

    Here is how I am invoking the pileup/mutation calling:

    samtools mpileup -d10000000 -BRuf ~/hg19.fa alignment.bam | bcftools view -vcg ->snps.vcf
    I have tried varying the -t and -p options in bcftools view without success.

    If I omit -v from bcftools, I see that bcftools is not regarding the position as a variant. Here is the output from that line:

    chrX 66941716 . G . 283 . DP=113309;AF1=0;AC1=0;DP4=54138,47121,4400,3713;MQ=25;FQ=-282;PV4=0.18,1,1,1 PL 0
    So as you should see there are significant reads at the position that should support the SNP. Does anyone have any suggestions?
  • sowalsky
    Junior Member
    • Oct 2012
    • 4

    #2
    Just a follow-up. By using:

    samtools mpileup -d10000000 -BRuf ~/hg19.fa alignment.bam | bcftools view -p 2 -vcg ->snps.vcf
    it forced bcftools to consider my mutation but it gave it a really poor quality score. It found:

    chrX 66941716 . G A -0 . DP=113309;AF1=0;AC1=0;DP4=54138,47121,4400,3713;MQ=25;FQ=-282;PV4=0.18,1,1,1 GT:PL:GQ 0/0:0,255,255:99
    The original bam file was from RNA-seq of a highly-heterogeneous population. Is there a way to control for this, so bcftools would accept this as a genuine mutation and not score it so poorly?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...